Inventus Mining Closes $1M Flow-Through Private Placement With Eric Sprott
GlobeNewswire· 2025-05-22 20:23
Not for Distribution to United States Wire Services or Dissemination in The United States TORONTO, May 22, 2025 (GLOBE NEWSWIRE) -- Inventus Mining Corp. (TSX VENTURE: IVS) (“Inventus” or the “Company”) is pleased to report that it has closed a non-brokered private placement of 8,000,000 flow-through shares within the meaning of the Income Tax Act (Canada) (“FT Shares”), which were sold at $0.13 per FT Shares for gross proceeds of $1,040,000 (the “Private Placement”). Mr. Eric Sprott was the sole subscriber ...
Uniti Group Inc. to Participate at the Goldman Sachs 10th Annual Leveraged Finance and Credit Conference
GlobeNewswire· 2025-05-22 20:15
LITTLE ROCK, Ark., May 22, 2025 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its Senior Vice President, Chief Financial Officer and Treasurer, Paul Bullington, and Senior Vice President, Investor Relations & Treasury, Bill DiTullio, are scheduled to participate at the Goldman Sachs 10th Annual Leveraged Finance and Credit Conference on May 29, 2025 in Dana Point, CA. Any investor materials will be made available on Uniti’s Investor Relations website at investor.uniti.co ...
Stifel Reports April 2025 Operating Data
GlobeNewswire· 2025-05-22 20:15
ST. LOUIS, May 22, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for April 30, 2025 in an effort to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed. Ronald J. Kruszewski, Chairman and Chief Executive Officer, said, “Total client assets and fee-based assets increased 7% and 11%, respectively, from the same period a year ago, due ...
Quanex Building Products Announces Second Quarter 2025 Earnings Release and Conference Call Schedule
GlobeNewswire· 2025-05-22 20:15
Core Points - Quanex Building Products Corporation plans to release its second quarter 2025 results on June 5, 2025, after market close [1] - A conference call is scheduled for June 6, 2025, at 11:00 a.m. ET to discuss the results, with a live audio webcast available on the company's website [2] - Quanex is a global manufacturer with capabilities across various end markets, focusing on innovative solutions in sectors such as windows, doors, and cabinetry [3] Company Overview - Quanex collaborates with leading OEMs to provide solutions in multiple markets, including solar and refrigeration [3] - The company aims to leverage its material science expertise to expand into adjacent markets in the future [3]
Nexxen and VIDAA Sign Non-Binding MOU to Extend and Expand Strategic Partnership
GlobeNewswire· 2025-05-22 20:15
Agreement would extend Nexxen’s global ACR data exclusivity with VIDAA, while adding display ad monetization exclusivity across VIDAA’s media in North AmericaNEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced it has signed a non-binding memorandum of understanding (“MOU”) with VIDAA to potentially extend and expand their existing strate ...
Everbright Digital Holdings Limited Announces Closing of Partial Exercise of Over-Allotment Option
GlobeNewswire· 2025-05-22 20:15
HONG KONG, May 22, 2025 (GLOBE NEWSWIRE) -- Everbright Digital Holdings Limited (the “Company” or “Everbright”) (Nasdaq: EDHL), an integrated marketing solutions provider headquartered in Hong Kong, today announced that it has issued an additional 160,000 ordinary shares (the “Ordinary Shares”) at a price of US$4.00 per share for gross proceeds of approximately $640,000, before deducting underwriter discounts and other related expenses, pursuant to the partial exercise of the underwriter’s over-allotment op ...
Americold Realty Trust, Inc. Sets Date for Second Quarter 2025 Earnings Release and Conference Call
GlobeNewswire· 2025-05-22 20:15
ATLANTA, GA., May 22, 2025 (GLOBE NEWSWIRE) -- Americold Realty Trust (NYSE: COLD), a global leader in temperature-controlled logistics, real estate, and value-added services focused on the ownership, operation, acquisition and development of temperature-controlled warehouses, today announced that the Company will release second quarter 2025 financial results before the market opens on Thursday, August 7, 2025. A conference call will be held on Thursday, August 7, 2025 at 8:00 a.m. Eastern Time. Webcast:A w ...
WORK Medical Technology Group LTD Announces Closing of Registered Offering
GlobeNewswire· 2025-05-22 20:10
Hangzhou, China, May 22, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced the closing of a registered offering (the “Offering”) of 10,000,000 ordinary units (the “Ordinary Units”) at an offering price of $0.50 per Ordinary Unit. Each Ordinary Unit consists of one Class A ordinary share, ...
GENFIT Reports First Quarter 2025 Financial Information
GlobeNewswire· 2025-05-22 20:10
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 22, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its cash position as of March 31, 2025 and revenues for the first three months of 2025.1 Cash position As of March 31, 2025, the Company’s cash and cash equivalents amounted to €129.5 million compared with €74.0 million as of March 31 ...
Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors
GlobeNewswire· 2025-05-22 20:10
Dr. Read brings >30 years of leadership and scientific expertise in the biopharmaceutical industry Previously served as CEO and Founder of Mariana Oncology until its acquisition by Novartis in 2024 and CSO of Ra Pharma until its acquisition by UCB in 2020 NEW YORK and WALTHAM, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune disea ...